You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 4, 2025

Details for Patent: 11,318,130


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,318,130 protect, and when does it expire?

Patent 11,318,130 protects ZYCLARA and is included in one NDA.

This patent has thirty-five patent family members in thirty countries.

Summary for Patent: 11,318,130
Title:2x2x2 week dosing regimen for treating actinic keratosis with pharmaceutical compositions formulated with 3.75% imiquimod
Abstract: Pharmaceutical formulations and methods for the topical or transdermal delivery of 1-isobutyl-1H-imidazo[4,5-c]-quinolin-4-amine or 1-(2-methylpropyl)-1H-imidazo[4,5-c]quinolin-4-amine, i.e., imiquimod, to treat actinic keratosis with short durations of therapy, than currently prescribed for the commercially available Aldara.RTM. 5% imiquimod cream, as now approved by the U.S. Food & Drug Administration ("FDA"), are disclosed and described. More specifically, lower dosage strength imiquimod formulations to deliver an efficacious dose of imiquimod for treating actinic keratosis with an acceptable safety profile and dosing regimens that are short and more convenient for patient use than the dosing regimen currently approved by the U.S. Food & Drug Administration ("FDA") for Aldara.RTM. 5% imiquimod cream to treat actinic keratosis are also disclosed and described.
Inventor(s): Nordsiek; Michael T. (Wayne, PA), Levy; Sharon F. (Philadelphia, PA), Lee; James Hurn-Joung (St. Paul, MN), Kulp; James H. (West Chester, PA), Balaji; Kodumudi S. (Lansdale, PA), Meng; Tze-Chiang (Lino Lakes, MN), Wu; Jason J. (Wayne, PA), Bahm; Valyn S. (Phoenixville, PA), Babilon; Robert (Boyertown, PA)
Assignee: Medicis Pharmaceutical Corporation (Bridgewater, NJ)
Application Number:16/268,230
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,318,130: A Comprehensive Guide

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 11,318,130, using various resources and datasets to provide a thorough analysis.

Understanding Patent Claims

Definition and Purpose

Patent claims define the matter for which protection is sought. They must be clear, concise, and fully supported by the description provided in the patent application[5].

Structure and Requirements

Claims are numbered consecutively and must be reasonable in number considering the nature of the invention. They can be independent or dependent, with dependent claims referring to other claims in the application[5].

The Patent Claims Research Dataset

The USPTO's Patent Claims Research Dataset is a valuable resource for analyzing patent claims. It includes detailed information on claims from U.S. patents granted between 1976 and 2014 and U.S. patent applications published between 2001 and 2014. This dataset can help in understanding claim language, independent claim length, and independent claim count, which are metrics used to measure patent scope[2].

Measuring Patent Scope

Independent Claim Length and Count

Research has shown that independent claim length and count are simple yet effective metrics for measuring patent scope. These metrics have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, the breadth of patent classes, and novelty[3].

Analyzing Patent 11,318,130

Patent Details

To analyze the scope and claims of United States Patent 11,318,130, one would typically start by accessing the patent document through databases such as the USPTO's Patent Public Search or the PATENTSCOPE database provided by WIPO[4].

Claim Analysis

  • Claim Structure: Examine the number and structure of the claims. Are they clear and concise? Are they fully supported by the description?
  • Independent vs. Dependent Claims: Identify the independent claims, which define the invention broadly, and the dependent claims, which narrow down the invention.
  • Claim Length and Count: Analyze the length and number of independent claims to gauge the patent's scope.

Scope of Protection

The scope of protection is defined by the claims. A narrower scope might indicate a more specific invention, while a broader scope could suggest a more general claim. The analysis should consider whether the claims are overly broad or if they are narrowly tailored to the invention described.

Citation Analysis

Citations made to and from the patent can provide insights into its impact and relevance. The PatentsView database and the USPTO's datasets on citations can be used to analyze forward and backward citations, which can indicate the patent's influence and its position within the broader patent landscape[1][2].

International Patent Classification (IPC) and Cooperative Patent Classification (CPC)

Understanding the classification of the patent under IPC or CPC can help in identifying similar patents and assessing the competitive landscape. These classifications provide a structured way to categorize inventions and can be used to search for related patents globally[4].

Non-Patent Citations

Non-patent citations, such as articles and papers mentioned in the patent, can provide context on the state of the art and the scientific or technological background of the invention. This information can be found in datasets that include non-patent citations mentioned in granted patents[1].

Economic and Legal Implications

The scope and claims of a patent have significant economic and legal implications. Broader claims can lead to increased licensing and litigation costs, while narrower claims may result in a shorter examination process and higher probability of grant[3].

Case Study: Patent 11,318,130

Example Analysis

  • Claim 1: If the first claim is broad and encompasses a wide range of applications, it may indicate a broader scope of protection.
  • Dependent Claims: If there are several dependent claims, they may narrow down the invention to specific embodiments.
  • Citations: Analyze the forward and backward citations to understand the patent's impact and its place in the technological landscape.
  • Classification: Check the IPC or CPC classification to identify similar patents and assess the competitive landscape.

Key Takeaways

  • Clear and Concise Claims: Ensure that the claims are clear, concise, and fully supported by the description.
  • Scope Metrics: Use independent claim length and count to measure the patent's scope.
  • Citation Analysis: Analyze citations to understand the patent's influence and relevance.
  • Classification: Use IPC or CPC classifications to identify related patents and assess the competitive landscape.
  • Economic Implications: Consider the economic implications of broader or narrower claims on licensing and litigation costs.

FAQs

Q: What are the key components of a patent claim?

A: Patent claims must define the matter for which protection is sought, be clear and concise, and be fully supported by the description.

Q: How can the scope of a patent be measured?

A: The scope can be measured using metrics such as independent claim length and independent claim count.

Q: What is the significance of citations in patent analysis?

A: Citations indicate the patent's influence and relevance within the broader patent landscape.

Q: How do IPC and CPC classifications help in patent analysis?

A: These classifications help in identifying similar patents and assessing the competitive landscape.

Q: What are the economic implications of broader patent claims?

A: Broader claims can lead to increased licensing and litigation costs.

Sources

  1. PatentsView - Data Download Tables - PatentsView
  2. USPTO - Patent Claims Research Dataset
  3. SSRN - Patent Claims and Patent Scope
  4. Clemson University - Research and Course Guides: Patent Searching, Advanced: Overview
  5. USPTO - The Claims - USPTO

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,318,130

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch ZYCLARA imiquimod CREAM;TOPICAL 022483-002 Jul 15, 2011 RX Yes Yes ⤷  Subscribe ⤷  Subscribe TREATMENT OF ACTINIC KERATOSIS ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.